Contact
: Taylor & Francis Executive Editor, [email protected].
Editor-in-Chief
Leslie Citrome, MD, MPH
Clinical Professor of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, NY, USA
(Dr Citrome has disclosed that he is a consultant for: AbbVie/Allergan, Acadia, Adamas, Alkermes, Angelini, Astellas, Avanir, Axsome, BioXcel, Boehringer Ingelheim, Cadent Therapeutics, Cerevel, COMPASS, Eisai, Enteris BioPharma, HLS Therapeutics, INmune Bio, Impel, Intra-Cellular Therapies, Janssen, Karuna, Lundbeck, Lyndra, Medavante-ProPhase, Merck, Neurocrine, Neurelis, Novartis, Noven, Otsuka, Ovid, Praxis, Relmada, Reviva, Sage, Sunovion, Supernus, Teva, University of Arizona, and also provides one-off ad hoc consulting for individuals/entities conducting marketing, commercial, or scientific scoping research. He is also a speaker for: AbbVie/Allergan, Acadia, Alkermes, Angelini, BioXcel, Eisai, Intra-Cellular Therapies, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sage, Sunovion, Takeda, Teva, and CME activities organized by medical education companies such as Medscape, NACCME, NEI, Vindico, and Universities and Professional Organizations/Societies. He holds stocks (small number of shares of common stock) in: Bristol-Myers Squibb, Eli Lilly, J & J, Merck, Pfizer purchased more than10 years ago and stock options: Reviva.
He also receives royalties/publishing from: Wiley (Editor-in-Chief, International Journal of Clinical Practice, through end 2019), UpToDate (reviewer), Springer Healthcare (book), Elsevier (Topic Editor, Psychiatry, Clinical Therapeutics).
Editor Emeritus
Dimitri P. Mikhailidis, MD, FFPM, FRCP, FRCPath
Reader and Academic Head, Department of Clinical Biochemistry
Royal Free Hospital and University College Medical School
London, UK
Editorial Board
Raid Alany
Chair in Pharmaceutics
School of Pharmacy and Chemistry
Kingston University London
Penrhyn Road
Kingston upon Thames
Surrey KT1 2EE
Prof. Alany has disclosed that he has no relevant financial relationships.
Carl V. Asche
Director, Center for Outcomes Research,
University of IllinoisCollege ofMedicine at Peoria
Peoria, IL, USA
Dr Asche has disclosed that he is the recipient of research/grant funding from Takeda, Abbott and Novartis, and that he is a consultant/advisor to Sanofi-Aventis.
Anthony H. Barnett, MD, FRCP
Professor of Medicine, Honorary Consultant Physician
University of Birmingham Medical School
Birmingham, UK
Prof. Barnett has disclosed that he has received honoraria for lectures and advisory work from MSD, Novartis, Boeheringer-Ingelheim, Astra-Zeneca, Janssen, Eli Lilly, Sanofi-Aventis and Novo Nordisk.
Nicholas Bellamy
Centre of National Research on Disability and Rehabilitation Medicine
The University of Queensland
Brisbane, Australia
Emeritus Prof. Bellamy has disclosed that he is the owner of the WOMAC trademark and copyrights to WOMAC, AUSCAN, 02MS, OGI and WOMBAT health status instruments and PARIS sectogram.
Jonathan Belsey, MD
JB Medical Ltd.
Little Cornard, Sudbury, Suffolk, UK
Dr Belsey has disclosed that he has been a consultant to Avita Medical Ltd, Bayer plc, Daiichi-Sankyo Europe, EUSA Pharma, GlaxoSmithKline, Ipsen Pharma, Janssen EMEA, Janssen UK, Menarini Pharma UK and Norgine Lttd
Kathryn Blake
Biomedical Research Department
Nemours Children’s Speciality Care
Jacksonville, FL, USA
Dr Blake has disclosed that she has no relevant financial relationships.
Christopher M. Blanchette
College of Health and Human Services
University of North Carolina,
Charlotte, NC, USA
Dr Blanchette has disclosed that he is the recipient of research/grant funding from GlaxoSmithKline, AstraZeneca, Merck, Covidien and Boehringer-Ingelheim, and is a consultant/advisor to GlaxoSmithKline, Sepracor, AstraZeneca and Novartis.
Eric G. Boyce
Department of Pharmacy Practice
University of the Pacific
Stockton, CA, USA
Dr Boyce has disclosed that he has no relevant financial relationships.
Olivier Bruyere
Department of Public Health, Epidemiology and Health Economics
Liege University
Liege, Belgium
Prof. Bruyère has disclosed that he has received grant support from Bayer, IBSA, MEDA, MSD, Nutraveris, Novartis, Pfizer, Rottapharm, Servier, SMB and Theramex.
Zhao Chen
Mel and Enid Zuckerman College of Public Health
University of Arizona
Tuscon, AZ, USA
Dr Zhao Chen has disclosed that she has no relevant financial relationships.
Judy W.M. Cheng
Massachusetts College of Pharmacy and Health Sciences
Boston, MA, USA
Prof. Cheng has disclosed that she has no relevant financial relationships.
Constantin A. Dasanu, MD, PhD
Clinical Professor of Medicine
University of California in San Diego, CA, USA
Eisenhower Health, CA, USA
Dr Dasanu has disclosed that he has no relevant financial relationships.
Lisa E. Davis
Philadelphia College of Pharmacy
University of the Sciences in Philadelphia
Philadelphia, PA, USA
Dr Davis has disclosed that her spouse is an employee of GlaxoSmithKline.
Andrea De Vito
Unit of Infectious Diseases
Department of Medicine, Surgery and Pharmacy
University of SassariSassari
Italy
Dr De Vito has no conflcits to disclose.
Moses S. Elisaf, MD, FRSH, FASA
Professor of Medicine, School of Medicine
University of Ioannina
Ioannina, Greece
Prof. Elisaf reports personal fees from Astra Zeneca, grants and personal fees from MSD, personal fees from Pfizer, personal fees and non-financial support from Abbott, personal fees and non-financial support from Sanofi, non-financial support from Boehringer INGELHEIM, personal fees and non-financial support from Eli Lilly, non-financial support and other from GSL.
Justin Faden DO
Lewis Katz School of Medicine, Temple University
Philadelphia, Pennsylvania, USA
Dr Faden disclosed receiving research support from BioXcel and being a non-paid consultant/advisor for Noven.
Alex Z. Fu
Department of Oncology
Georgetown University Medical Center
Washington, DC, USA
Prof. Fu has disclosed that he is the recipient of research/grant funding from Novartis, Merck & Co. Inc and is a consultant/advisor to CHEORS, Intuitive Surgical.
Nigel H. Greig
Translational Gerontology Branch
National Institute on Aging
NIH, Baltimore, MD, USA
Dr Greig has disclosed that that he is a shareholder of diversified stocks as well as some selected pharmaceutical stocks (particularly Elan and Amylin).
Paul O. Gubbins
Associate Dean at MSU
UMKC School of Pharmacy at MSU
Springfield, MO, USA
Dr Gubbins has disclosed that he has no relevant financial relationships.
Stuart T. Haines
The University of Mississippi
Oxford, MS, USA
Dr Haines has disclosed that he has no relevant financial relationships.
Kwok Ming Ho
Department of Anesthesia & Intensive Care, The Chinese University of Hong Kong
Hong Kong SAR, China
Department of Internal Medicine, University of Western Australia
Perth, Western Australia
Dr Ho has disclosed that he has no relevant financial relationships.
Michael Iskedjian
President, PharmIdeas Research and Consulting Oakville, ON, Canada
Mr Iskedjian has disclosed that he is a consultant/advisor to Amgen Inc., Ipsen Pharma, Nestle Nutrition Institute, Pfizer Inc., Sanofi Pasteur, Sepracor and Vertex Pharmaceuticals; has invested in the past, and may continue to invest in, broad mutual funds which from time to time may hold stock in pharmaceutical companies; and is an employee of PharmIdeas Research and Consulting.
Moyez Jiwa
Melbourne Clinical School
University of Notre Dame
Victoria, Australia
Prof. Jiwa has disclosed that he has no relevant financial relationships.
Siegfried Kasper
Dept of General Psychiatry
Medical University of Vienna
Vienna, Austria
Prof. Kasper has disclosed that he is the recipient of sponsorship funding from AstraZeneca, Eli Lilly, Lundbeck, Bristol Myers Squibb, Sepracor, Servier, Novartis and Pfizer; is the recipient of research/grant funding from Eli Lilly, Lundbeck, Bristol-Myers Squibb, Sepracor, Servier, Novartis and Pfizer; is a consultant or advisor to Astra-Zeneca, Bristol-Myers Squibb, Eli Lilly, Lundbeck, Pfizer, Janssen Pharmaceutica, Sepracor, Servier, Pierre Fabre, Wyeth, Merck Sharpe & Dohme and Schwabe; and is a member of the speakers bureaus of Astra-Zeneca, Bristol-Myers Squibb, Eli Lilly, Lundbeck, Janssen Pharmaceuticals, Pierre Fabre, Organon, CSC, Servier, Pfizer and GlaxoSmithKline.
Niki Katsiki, MSc, PhD, MD, FRSPH
Second Propedeutic Department of Internal Medicine, Medical School
Aristotle University of Thessaloniki
Hippokration Hospital
Thessaloniki, Greece
Dr. Katsiki has disclosed that she has given talks and attended conferences sponsored by Astra-Zeneca, MSD, Novo-Nordisk, Angelini, Novartis, Pfizer, WinMedica and Libytec and also participated in trials sponsored by Amgen and Novartis.
Gerald L Klein MD
Adjunct Professor of Pharmacology, Brody School of Medicine, East Carolina University
North Carolina, USA;
Principal, MedSurgPi LLC
North Carolina, USA
Dr Klein has disclosed that MedSurgPi LLC is a consulting group that consults for CROs, Biotech and pharma.
Peter Y. Liu
ANZAC Research Institute, Concord Repatriation General Hospital
University of Western Sydney
Concord, Australia
Dr Liu has disclosed that he is a recipient of research/grant funding from Bayer Schering Australia.
Bradley C. Martin, PharmD, PhD
Professor and Director of Pharmaceutical Evaluation and Policy
University of Arkansas Medical Sciences
Little Rock, AK, USA
Prof. Martin has disclosed that he is a consultant/advisor for Daiichi Sankyo.
Sebastiano Mercadante, MD
Anesthesia and Intensive Care Unit and Pain Relief and Palliative Care Unit
La Maddalena Cancer Center, Palliative Medicine
University of Palermo, Italy
Dr Mercadante has disclosed that he has no relevant financial relationships.
Godfrey Nyangadzayi Musuka
International Initiative for Impact Evaluation
New Delhi
India
Dr Musuka has disclosed that he has no relevant financial relationships.
Jadwiga Najib
Professor of Pharmacy Practice
Long Island University
Brooklyn, NY, USA
Clinical Pharmacist
Department of Pharmacy and Psychiatry
St Luke’s/Roosevelt Hospital Center
New York, NY, USA
Prof.Najib has disclosed that she has no relevant financial relationships.
Dr Anthony D. Ormerod MB, ChB, MRCP, FRCP(Edin), MD, FRCP(Lond)
University of Aberdeen, King’s College, Aberdeen City, Aberdeen, UK
Dr Ormerod disclosed that he is the recipient of sponsorship for meeting attendance by Janssen-Cilag; has received research/grant funding from Merck & Co, and Abbott; and has been a consultant to Amgen.
Panagiotis Petrou
Adjunct Facility, Pharmacoepidemiology-Pharmacovigilance, Pharmacy School, Department of Health Sciences, University of Nicosia
Nicosia, Cyprus
Professor Petrou has disclosed that he has no relevant financial relationships.
John Plevris, MD, DM, PhD, FRCPE, FEBGH
Consultant Physician and Senior Lecturer, Centre for Liver and Digestive Diseases, Royal Infirmary of Edinburgh
University of Edinburgh
Edinburgh, UK
Professor Plevris has disclosed that he has been a recipient of research/grant funding from Aquilant and has been on the advisory board of Dr Falk.
J. Mark Ruscin
SIU Edwardsville School of Pharmacy
Southern Illinois University
Edwardsville, IL, USA
Prof. Ruscin has disclosed that he has no relevant financial relationships.
Cynthia Sanoski
Jefferson School of Pharmacy
Philadelphia, PA, USA
Dr Sanoski has disclosed that she has no relevant financial relationships.
Michael Schachter, FRCP
Senior Lecturer and Honorary Consultant in Clinical Pharmacology
National Heart and Lung Institute, Imperial College London, St Marys Campus
London, UK
Terry L. Seaton
St Louis College of Pharmacy
St Louis, MO, USA
Dr Seaton has disclosed that he is consultant/advisor to Ciena Healthcare Pharmacy and Therapeutics Committee.
Leo P. Semes
Dept of Optometry
University of Alabama
Birmingham, AL, USA
Prof. Semes has disclosed that he is advisor to/Speakers’ Bureau for Alcon, Allergan, B&L, Genentech, Maculogix, OptoVue, Shire, Zeavision; Stock holder of HPO.
Dr Schachter has disclosed that he has no relevant financial relationships.
David Shavelle, MD
Keck School of Medicine, University of Southern California, Los Angeles, CA USA
Dr Shavelle has disclosed that he is the recipient of research/grant funding from CSK, St Jude Medical, Marquet, Inc., Merck & Co. Inc and is a consultant/advisor to sanofi-aventis US.
Lizheng Shi, PhD
Tulane University School of Public Health and Tropical Medicine, New Orleans, LA USA
Dr Shi has disclosed that he is the recipient of research/grant funding from Bristol Myers Squibb and has acted as a consultant/advisor to Cepheid Inc.
Gerard Stansby, MA, FRCS, MChir
Professor of Vascular Surgery and Honorary Consultant in Vascular Surgery
School of Surgical & Reproductive Sciences, Newcastle University
Newcastle, UK
Prof. Stansby has disclosed that he has no relevant financial relationship.
David M. Taylor
Chief Pharmacist, Maudsley Hospital
South London and Maudsley NHS Trust
London, UK
Prof. Taylor has disclosed that he is a recipient of grants or research funding from Janssen, Lundbeck and Sunovion; has received lecture fees from Janssen, Otsuka, Servier, Lundbeck and Sunovion.
Karen J. Tietze
Philadelphia College of Pharmacy
University of the Sciences in Philadelphia
Philadelphia, PA, USA
Dr Tietze has disclosed that she has no relevant financial relationships.
Justin A. Vale
St Mary’s Hospital
London, UK
Mr Vale has disclosed that he has no relevant financial relationships.
Timothy E. Welty
Kansas University Medical Center
Kansas City, KS, USA
Prof. Welty has disclosed that he is the recipient of research/grant funding from Pfizer Pharmaceuticals.
Anthony S. Wierzbicki, DPhil, DM, FRCPath
Consultant in Metabolic Medicine and Chemical Pathology and Senior Lecturer
King’s, Guy’s & St. Thomas’ Medical School, St. Thomas’ Hospital Campus
London, UK
Dr Wierzbicki has disclosed that he is a site trial investigator for Amgen, Sanofi, Akcea, Merck Sharp & Dohome and Chiesi.
Masha Zhdanava
Manager, Analysis Group
Montreal, Canada
M Zhdanava discloses that she is an employee of Analysis Group, a company that provides paid consulting services to pharmaceutical companies. She is currently actively involved in research for Johnson & Johnson Innovative Medicine (2023-2024).
Current Medical Research and Opinion is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110817/Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
![A new way for Wellcome-funded researchers to rapidly publish any results they think are worth sharing.]({"type":"image" , "src" : "/sda/112430/Genetics-general-medicine-KB.jpg"})